-
Trichostatin A (TSA): Potent HDAC Inhibitor for Epigeneti...
2026-02-24
Trichostatin A (TSA) is a reversible, noncompetitive histone deacetylase inhibitor widely used in epigenetic and cancer research. TSA (SKU A8183) shows nanomolar antiproliferative activity in breast cancer cell lines and enables precise modulation of histone acetylation pathways. This dossier provides atomic, evidence-backed insights into TSA’s mechanism, applications, and practical guidelines for robust experimental design.
-
Polymyxin B Sulfate: Optimizing Gram-Negative Infection R...
2026-02-24
Polymyxin B (sulfate) is more than a last-resort antibiotic—it is a versatile tool for multidrug-resistant Gram-negative bacteria research, immune modulation assays, and translational sepsis models. This article delivers actionable workflows, troubleshooting strategies, and comparative insights to help scientists harness the full potential of APExBIO’s Polymyxin B (sulfate) in advanced experimental settings.
-
Puromycin dihydrochloride (SKU B7587): Precision Selectio...
2026-02-23
This article delivers scenario-driven, evidence-based guidance for deploying Puromycin dihydrochloride (SKU B7587) as a reliable aminonucleoside antibiotic in molecular biology workflows. Learn how this protein synthesis inhibitor optimizes cell viability assays, cell line selection, and translational studies, with direct links to protocols and peer-reviewed research. APExBIO’s Puromycin dihydrochloride is positioned for reproducibility and scientific rigor.
-
Puromycin Dihydrochloride: Precision Tools for Protein Sy...
2026-02-23
Explore the multifaceted role of puromycin dihydrochloride as a protein synthesis inhibitor and selection marker for pac gene in advanced molecular biology research. This article offers a unique, mechanistically driven perspective on optimizing puromycin selection and translational pathway studies.
-
Trichostatin A (TSA): Precision HDAC Inhibitor for Epigen...
2026-02-22
Trichostatin A (TSA) is a potent histone deacetylase inhibitor used in epigenetic regulation and cancer research. TSA induces histone hyperacetylation, cell cycle arrest, and differentiation in mammalian cells, with strong evidence of antiproliferative effects in breast cancer and pancreatic models. Its high specificity and reproducibility make it a benchmark tool for investigating chromatin dynamics and therapeutic epigenetics.
-
Morin: Mechanistic Foundation for Precision Mitochondrial...
2026-02-21
Explore how Morin, a natural flavonoid antioxidant and fluorescent aluminum ion probe, serves as a mechanistic tool for precision modulation of mitochondrial energy metabolism in diabetes, neurodegeneration, and beyond. This article uniquely dissects Morin’s action on adenosine 5′-monophosphate deaminase and offers translational insights for advanced research workflows.
-
Stiripentol: LDH Inhibitor Workflows for Epilepsy & Tumor...
2026-02-20
Stiripentol empowers researchers to dissect lactate metabolism and astrocyte-neuron lactate shuttle modulation with unmatched specificity for LDH1 and LDH5. This guide delivers actionable protocols and troubleshooting strategies, advancing both epilepsy and tumor immunometabolism research with APExBIO's high-purity Stiripentol.
-
Azathramycin A: A Macrolide Antibiotic for Tuberculosis R...
2026-02-20
Azathramycin A delivers targeted inhibition of Mycobacterium tuberculosis ribosomes, enabling high-fidelity modeling of bacterial protein synthesis inhibition and antibiotic resistance. Its robust solubility and specificity make it a premier choice for advanced TB infection research and translational workflows.
-
Stiripentol: Noncompetitive LDH Inhibitor for Epilepsy an...
2026-02-19
Stiripentol is a high-purity, noncompetitive LDH inhibitor that modulates the astrocyte-neuron lactate shuttle, enabling precise investigation of lactate metabolism in epilepsy and immunometabolic research. Its unique mechanism and validated purity make it a critical compound for Dravet syndrome studies and broader metabolic pathway interrogation.
-
Azathramycin A: Macrolide Ribosome Inhibitor for Tubercul...
2026-02-19
Azathramycin A is a macrolide antibiotic and ribosome inhibitor of Mycobacterium tuberculosis, serving as a benchmark for antibacterial agent development in TB research. This article details its mechanism, evidentiary benchmarks, and practical integration, offering researchers actionable, verifiable insights.
-
Polymyxin B (sulfate): Beyond Antimicrobial Action in Gra...
2026-02-18
Explore the multifaceted roles of Polymyxin B (sulfate) as a polypeptide antibiotic for multidrug-resistant Gram-negative bacteria. Discover new scientific insights into its immunomodulatory effects, advanced assay applications, and translational significance in infection and immune research.
-
Azathramycin A: Mechanistic Leverage and Translational St...
2026-02-18
This thought-leadership article examines Azathramycin A—an advanced macrolide antibiotic and ribosome inhibitor of Mycobacterium tuberculosis (Mtb)—from mechanistic underpinnings to translational applications. Integrating the latest pharmacokinetic-pharmacodynamic evidence, comparative benchmarking, and forward-looking guidance, it provides strategic insight for researchers seeking robust tools for protein synthesis inhibition, tuberculosis infection modeling, and antibiotic resistance studies. With reference to both APExBIO’s product standards and the evolving landscape of macrolide therapeutics, the article offers a differentiated, scenario-driven perspective on deploying Azathramycin A for maximal scientific and translational impact.
-
Morin (C5297): Natural Flavonoid Antioxidant and Mitochon...
2026-02-17
Morin is a high-purity natural flavonoid antioxidant acting as a mitochondrial energy metabolism modulator and potent adenosine 5′-monophosphate deaminase inhibitor. Supplied by APExBIO, Morin’s verified bioactivity enables reproducible research in diabetes, neurodegeneration, and cancer models.
-
Cycloheximide in Translational Research: Mechanistic Prec...
2026-02-17
Explore how Cycloheximide, a gold-standard protein biosynthesis inhibitor, drives mechanistic insights and strategic innovation in translational research. This article provides an integrated overview of the biological rationale, experimental validation, and competitive landscape—while extending the discussion into visionary applications for disease modeling, apoptosis, and post-translational protein regulation.
-
Trichostatin A: HDAC Inhibitor for Advanced Epigenetic Re...
2026-02-16
Trichostatin A (TSA) from APExBIO empowers cancer and epigenetic researchers with precise, reproducible control over histone acetylation and gene expression. Discover robust experimental workflows, advanced use-cases, and actionable troubleshooting strategies for leveraging this gold-standard HDAC inhibitor in both foundational and translational studies.
508 records 24/34 page Previous Next First page 上5页 2122232425 下5页 Last page